References
- Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. 2nd ed. New York: Guilford Press, 2002.
- Roemer L, Orsillo SM. Expanding our conceptualization of and treatment for generalized anxiety disorder: integrating mindfulness/acceptance-based approaches with existing cognitive- behavioral models. Clin Psychol Sci Pr 2002; 9: 54–68.
- Charney DS. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr Scand Suppl 2003; 417: 38–50.
- Wittchen HU, Hoyer J. Generalized anxiety disorder: nature and course. J Clin Psychiatry 2001; 62(Suppl 11): 15–9.
- Kessler RC, Wittchen HU. Patterns and correlates of generalized anxiety disorder in community samples. J Clin Psychiatry 2002; 63(Suppl 8): 4–10.
- Wittchen HU, Kessler RC, Beesdo K, Krause P, Hofler M, Hoyer J. Generalized anxiety and depression in primary care: prevalence, recognition, and management. J Clin Psychiatry 2002; 63(Suppl 8): 24–34.
- Fricchione G. Clinical practice. Generalized anxiety disorder. N Engl J Med 2004; 351: 675–82.
- Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990; 28: 487–95.
- Kapczinski F, Lima MS, Souza JS, Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev 2003; (2): CD003592.
- Allgulander C, Bandelow B, Hollander E, Montgomery SA, Nutt DJ, Okasha A, et al. WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr 2003; 8(Suppl 1): 53–61.
- Ladouceur R, Dugas MJ, Freeston MH, Leger E, Gagnon F, Thibodeau N. Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial. J Consult Clin Psychol 2000; 68: 957–64.
- Borkovec TD, Newman MG, Caston- guay LG. Cognitive-behavioral therapy for generalized anxiety disorder with integrations from interpersonal and experiential therapies. CNS Spectr 2003; 8: 382–9.
- Barsky AJ, Ahern DK. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA 2004; 291: 1464–70.
- Magarinos M, Zafar U, Nissenson K, Blanco C. Epidemiology and treatment of hypochondriasis. CNS Drugs 2002; 16: 9–22.
- Looper KJ, Kirmayer LJ. Hypochondriacal concerns in a community population. Psychol Med 2001; 31: 577–84.
- Barsky AJ, Ettner SL, Horsky J, Bates DW. Resource utilization of patients with hypochondriacal health anxiety and somatization. Med Care 2001; 39: 705–15.
- Oosterbaan DB, van Balkom AJ, van Boeijen CA, de Meij TG, van Dyck R. An open study of paroxetine in hypochondriasis. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 1023–33.
- Fallon BA, Qureshi AI, Schneier FR, Sanchez-Lacay A, Vermes D, Feinstein R, et al. An open trial of fluvoxamine for hypochondriasis. Psychosomatics 2003; 44: 298–303.
- Fallon BA. Pharmacotherapy of somatoform disorders. J Psychosom Res 2004; 56: 455–60.
- Walker J, Vincent N, Furer P, Cox B, Kjernisted K. Treatment preference in hypochondriasis. J Behav Ther Exp Psychiatry 1999; 30: 251–8.
- Visser S, Bouman TK. The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behav Res Ther 2001; 39: 423–42.
- Clark DM, Salkovskis PM, Hackmann A, Wells A, Fennell M, Ludgate J, et al. Two psychological treatments for hypochondriasis. A randomised controlled trial. Br J Psychiatry 1998; 173: 218–25.
- Warwick HM, Clark DM, Cobb AM, Salkovskis PM. A controlled trial of cognitive-behavioural treatment of hypochondriasis. Br J Psychiatry 1996; 169: 189–95.
- Rayburn NR, Otto MW. Cognitive-behavioral therapy for panic disorder: a review of treatment elements, strategies, and outcomes. CNS Spectr 2003; 8: 356–62.
- Hambrick JP, Weeks JW, Harb GC, Heimberg RG. Cognitive-behavioral therapy for social anxiety disorder: supporting evidence and future directions. CNS Spectr 2003; 8: 373–81.
- Foa EB, Rothbaum BO, Furr JM. Augmenting exposure therapy with other CBT procedures. Psychiatr Ann 2003; 33: 47–53.
- Jenike MA. Clinical practice. Obsessive-compulsive disorder. N Engl J Med 2004; 350: 259–65.
- Deckersbach T, Gershuny BS, Otto MW. Cognitive-behavioral therapy for depression. Applications and outcome. Psychiatr Clin North Am 2000; 23: 795–809.
- Pollack MH, Allgulander C, Bandelow B, Cassano GB, Greist JH, Hollander E, et al. WCA recommendations for the long-term treatment of panic disorder. CNS Spectr 2003; 8(Suppl 1): 17–30.
- Stein DJ, Ipser JC, Balkom AJ. Pharmacotherapy for social anxiety disorder. Cochrane Database Syst Rev 2000; (4): CD001206.
- Stein DJ, Zungu-Dirwayi N, van der Linden GJ, Seedat S. Pharmacotherapy for posttraumatic stress disorder. Cochrane Database Syst Rev 2000; (4): CD002795.
- Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, et al. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults. CNS Spectr 2003; 8(Suppl 1): 7–16.
- Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depression. Cochrane Database Syst Rev 1999; (4): CD001851.
- Foa EB, Franklin ME, Moser J. Context in the clinic: how well do cognitive- behavioral therapies and medications work in combination? Biol Psychiatry 2002; 52: 987–97.
- Huibers MJ, Beurskens AJ, Bleijenberg G, van Schayek CP. The effectiveness of psychosocial interventions delivered by general practioners. Cochrane Database Syst Rev 2003; (2): CD003494.